What’s the difference between baking powder and baking soda? It’s subtle, but significant 
How to support someone who is grieving: five research-backed strategies 
NASA Resumes Cygnus XL Cargo Docking with Space Station After Software Fix 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
The ghost of Robodebt – Federal Court rules billions of dollars in welfare debts must be recalculated 
6 simple questions to tell if a ‘finfluencer’ is more flash than cash 
Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission 
Astronomers have discovered another puzzling interstellar object − this third one is big, bright and fast 
Debate over H-1B visas shines spotlight on US tech worker shortages 
Dow Hits 50,000 as U.S. Stocks Stage Strong Rebound Amid AI Volatility 
The American mass exodus to Canada amid Trump 2.0 has yet to materialize 
The Beauty Beneath the Expressway: A Journey from Self to Service 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
U.S. Stock Futures Edge Higher as Tech Rout Deepens on AI Concerns and Earnings 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
Columbia Student Mahmoud Khalil Fights Arrest as Deportation Case Moves to New Jersey 
Is space worth the cost? Accounting experts say its value can’t be found in spreadsheets 
7-Eleven will begin test-driving 'Neubie', an autonomous, short-range delivery robot equipped with a camera-based autonomous driving system at a store in Seoul's Seocho district.
According to the convenience store chain, Neubie demonstrates outstanding maneuverability in urban areas and could deliver under various weather conditions.
7-Eleven will focus on the robot's systematic and operational improvement as it adjusts to the open, complex urban environment rather than limited indoor spaces like buildings and shops.
The convenience store chain will expand the robot's service area to 300 meters and introduce an additional number of robots in the next three months of the intensive trial period.
